login
Password reminder
Cardiovascular News
Contact the editor Visit Cardiovascular News Twitter feed Visit Cardiovascular News Facebook page
 

ViewFlex Xtra Intracardiac Echocardiography catheter gets FDA clearance


Tuesday, 10 Jul 2012 15:08
ViewFlex Xtra ICE catheter
ViewFlex Xtra ICE catheter

The US Food and Drug Administration (FDA) has given 510(k) clearance to St Jude Medical to market its ViewFlex Xtra Intracardiac Echocardiography (ICE) catheter. This new technology is designed to be used with the ViewMate Z Ultrasound console, a system that provides fast, clear images to help visualise cardiac structures and blood flow within the heart during complex electrophysiology or interventional procedures.


The images produced by the ViewFlex Xtra ICE catheter and the ViewMate Z Ultrasound console help physicians confirm the location of cardiac structures and blood flow during procedures such as radiofrequency ablation to treat arrhythmias and structural heart procedures to close atrial septal defects.

The ViewFlex ICE catheter has an ergonomic handle allowing for single handed, four-way tip deflection and self-locking steering. The new handle helps streamline procedures by providing increased maneuverability with the potential to minimise catheter repositioning.


“The ViewFlex Xtra catheter offers an advancement to the ViewMate Z Ultrasound console through its four-way tip deflection, a feature that allows physicians to more easily obtain desired viewing angles of the cardiac anatomy,” said Dhanunjay Lakkireddy, professor of Medicine and director of the Center for Excellence in Atrial Fibrillation and EP Research from the University of Kansas Medical Center in Kansas City, USA, who first used the new ViewFlex Xtra ICE Catheter. “The wide range of viewing options and high-quality images allow me to focus more on the patient and less on the catheter.”




Add New Comment

Most popular


Medical devices available in the EU before the USA are at higher risk for emergence of safety issues
Thursday, 30 Jun 2016
A cohort study has found that medical devices approved first in the European Union (EU) are associated with a greater rate of post-marketing safety alerts and recalls compared with devices approved ... Medical devices available in the EU before the USA are at higher risk for emergence of safety issues

Industry-sponsored meals linked to increased rate of prescribing brand-name drugs
Friday, 01 Jul 2016
A study, published in the JAMA: Internal Medicine, indicates that doctors who receive industry-sponsored meals have higher rates of brand-name drug prescriptions than alternative options within the ... Industry-sponsored meals linked to increased rate of prescribing brand-name drugs

CE mark for QT Vascular’s Chocolate Heart drug-coated balloon
Thursday, 07 Jul 2016
QT Vascular has received CE mark clearance for the sale and distribution of its Chocolate Heart drug-coated balloon for dilatation of the stenotic portion of coronary arteries for the purpose of ... CE mark for QT Vascular’s Chocolate Heart drug-coated balloon

Features


TAVI durability: A rose by any other name is still a rose
Wednesday, 20 Jul 2016
The data that Dvir presented at EuroPCR, as reported by Cardiovascular News, indicate that there is a significant increase in valve degeneration between five and seven years after a transcatheter ... TAVI durability: A rose by any other name is still a rose

Exploring the borders of TAVI
Monday, 11 Jul 2016
The NOTION 2 trial, which recently enrolled a 64-year-old female with Society of Thoracic Surgeon (STS) score 1.2% as its first patient, is comparing the use of TAVI with the use of surgical aortic ... Exploring the borders of TAVI

Profiles


James Blankenship
Wednesday, 08 Jun 2016
James Blankenship is the 2015–2016 president of SCAI and has been involved with designing and ... James Blankenship

Alexandra Lansky
Monday, 07 Mar 2016
Alexandra Lansky (Director, Heart and Vascular Clinical Research Program, Yale University School of ... Alexandra Lansky

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions